S 1366 Massachusetts Senate · 193rd Legislature (2023-2024)

An Act improving newborn screening tests

This bill amends Massachusetts law to expand the state's newborn screening program by adding five specific genetic disorders to the list of conditions tested for at birth. The legislation directly affects infants born in the state by ensuring their blood samples are analyzed for Krabbe, Fabry, Gaucher, Pompe, and Niemann Pick A/B diseases. By updating the legal text of Chapter 111, the bill mandates that these additional disorders be included in the standard screening panel used by the Department of Public Health. This change aims to enable earlier detection and treatment for these rare conditions, which are currently not part of the required screening.
Bill status passed 3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Feb 2023
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023 Last action Feb 15, 2024
Floor votes

How they voted

This bill passed the House. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
4
Key actions
1
Committee
1
Feb 16, 2023
Lower · Passed
House concurred
lower
Feb 16, 2023
Committee
Referred to the committee on Public Health
upper
1 primary · 8 co-sponsors

Sponsors